That is, the relationship between the combination of elevated cTnT and high NT-proBNP and adverse outcomes was not influenced by age, sex, and whether there was a history of hypertension or CAD and the presence of ACS or HF (Figure 3). This evidence concerns the gene TNNT2 and hydrops fetalis.